The manipulation of cellular stiffness using pharmacological or genetic approaches targeting the actin cytoskeleton was proven to dictate the susceptibility of both murine cancer cell models and primary human cancer cells to perforin-mediated perforation. This evidence concerns the gene PRF1 and cancer.